Shine Technologies is a company that focuses on developing beam-target fusion devices because this form of fusion is the most cost-effective form of fusion and has near-term commercial applications. They produce one of the highest neutron fluxes of any fusion device. You can find more information about their products and services at their website https://www.shinefusion.com/.
Location: United States, Wisconsin, Janesville
Employees: 201-500
Total raised: $70M
Founded date: 2005
Investors 1
| Date | Name | Website |
| - | Koch Disru... | kochdisrup... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.10.2023 | - | $70M | - |
Mentions in press and media 10
| Date | Title | Description |
| 26.03.2026 | C-Ray Therapeutics and SHINE Technologies Enter Strategic Partnership for Exclusive Distribution of No-Carrier-Added Lu-177 in Mainland China | CHENGDU, China and JANESVILLE, Wis., March 26, 2026 /PRNewswire/ -- C-Ray Therapeutics (Chengdu, China), a global radiopharmaceutical CRDMO, today announced the execution of a Master Radioisotope Supply Agreement with SHINE Technologies, LL... |
| 27.02.2026 | SHINE Technologies Secures $240M, Propelling Fusion and Medical Isotopes Forward | SHINE Technologies secured $240 million in new equity funding, pushing its total capital raised beyond $1 billion. Dr. Patrick Soon-Shiong, a noted biotech visionary, joined its Board of Directors. This substantial investment will vigorousl... |
| 26.02.2026 | Shine Raises $240M in Funding | Shine Technologies, a Janesville, WI-based nuclear fusion company, raised $240M in equity funding. The round was led by NantWorks with additional participation from Fidelity Management and Research Company, Sumitomo Corporation of Americas,... |
| 19.02.2026 | Affibody Signs Letter of Intent with SHINE Technologies for Supply of Lutetium-177 | Affibody Signs Letter of Intent with SHINE Technologies for Supply of Lutetium-177 Thu, Feb 19, 2026 23:33 CET Report this content Stockholm, Sweden, February 19, 2026. Affibody AB (“Affibody”) today announced that a Letter of Intent (LOI) ... |
| 09.01.2025 | Antelope Surgical Solutions and SHINE Announce Partnership to Advance Clinical Radiopharmaceutical Development | Therapeutic radioisotope supply agreement. NEW YORK, NY, UNITED STATES, January 9, 2025 /EINPresswire.com/ -- Antelope Surgical Solutions, Inc., a biotechnology company pioneering next-generation multimodal radiopharmaceuticals, and SHINE T... |
| 19.10.2023 | SHINE Technologies: Fusion Technology Company Raises $70 Million | SHINE Technologies – a next-generation fusion technology company – recently announced it has raised $70 million in additional funding. The funding round was led by existing investors, including Baillie Gifford and Fidelity Management & ... |
| 11.10.2023 | Shine Technologies Raises $70M in Funding | Shine Technologies, a Janesville, WI-based fusion technology company, raised $70M in funding. The round was led by existing investors including Baillie Gifford and Fidelity Management & Research Company, and also included participation ... |
| 02.06.2022 | Live from the 20th Annual Wisconsin Entrepreneurs’ Conference | Wisconsin Technology Council’s annual conference was hosted in Milwaukee and brought together entrepreneurs and investors from across the state. Highlights of the conference included presentations from the finalists in the Governor’s Busin... |
| 02.05.2022 | Wisconsin Entrepreneurs’ Conference scheduled for June 1-2 in Milwaukee | The Wisconsin Entrepreneurs’ Conference, among the largest events targeted for entrepreneurs in the upper Midwest, will return to Milwaukee on June 1-2. The 20th annual conference, titled “Putting Early Stage Pieces Together,” will be an in... |
| - | SHINE Medical Technologies | “Discover SHINE Technologies' innovative approach to fusion technology, producing medical isotopes, recycling nuclear waste, and generating energy.” |